Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 2 75 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 2 75 25 SULFITE FREE IN DEXTROSE 25 IN PLASTIC CONTAINER versus KABIVEN IN PLASTIC CONTAINER.
CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% IN PLASTIC CONTAINER vs KABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
CLINIMIX 2.75/25 SULFITE FREE IN DEXTROSE 25% is a parenteral nutrition solution providing amino acids (essential and non-essential) for protein synthesis and dextrose as a caloric source. The amino acids serve as substrates for protein synthesis, supporting tissue repair and maintenance. Dextrose provides energy to prevent catabolism and promote anabolism.
Kabiven is a parenteral nutrition formulation that provides a balanced mixture of amino acids, dextrose, and lipids to meet nutritional requirements. The amino acids serve as building blocks for protein synthesis, dextrose provides a carbohydrate source for energy, and lipids supply essential fatty acids and additional energy. Electrolytes are included to maintain fluid and electrolyte balance.
Intravenous infusion. Typical adult dose: 500-2000 mL/day at a rate not exceeding 100 mL/hour based on caloric and nitrogen requirements. Maximum infusion rate: 100 mL/hour. Administered via central or peripheral line.
Intravenous infusion. Adult dose based on nutritional needs: typically 0.8-1.5 g amino acids/kg/day, 0.8-1.5 g lipids/kg/day, and 2-4 g dextrose/kg/day. Maximum infusion rate: 1.7 mL/kg/hour (Kabiven Peripher) or 2.6 mL/kg/hour (Kabiven Central).
None Documented
None Documented
Amino acid components: distribution t1/2 ~10–30 min, elimination t1/2 ~3–6 h (hepatic metabolism and renal clearance); dextrose: not applicable as it is rapidly used under insulin control.
Variable; amino acids: 0.5–1 h; lipids: 0.5–1 h (intralipid clearance); glucose: rapid. No true terminal half-life as a mixture.
Amino acids: renal elimination of nitrogen (urea), with ~90% of infused nitrogen recovered in urine; dextrose: primarily metabolized to CO2 and water, with <5% excreted renally unchanged under normal conditions.
Renal: <3% unchanged; primarily metabolized via protein catabolism; nitrogen excretion is renal (urea, ammonia); fat emulsion components are cleared by the reticuloendothelial system and metabolized. Biliary/fecal: negligible.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition